📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-27 09:25
453 analysed today
453
Today
133,342
All-time analysed
40,106
Positive
6,279
Negative
79,144
Neutral
7,745
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
14 announcements match the current filters (relevance ≥ 5).
Mitsu Chem Plast Adds 600 MT/Year Capacity; Cumulative FY27 Expansion Reaches 6,700 MT/Year
Mitsu Chem Plast Limited announced an additional capacity expansion of ~600 MT/Year across its manufacturing operations, augmenting its base capacity of 36,000+ MT/Year. This brings the company's cumulative capacity additions in FY27 to 6,700 MT/Year (~18.6% increase over FY26 base), following additions of 2,550 MT/Year in June 2026 and 3,550 MT/Year earlier in August 2026. Capacity utilization for FY26 stood at 64%, and the scale-up is aimed at meeting demand in industrial packaging, healthcare, and infrastructure segments.
Confidence: HIGH
What changedMitsu Chem Plast added 600 MT/Year of capacity, bringing its cumulative FY27 expansion to 6,700 MT/Year.
Why it mattersSupports product diversification and caters to rising demand from industrial packaging and healthcare OEM customers, building volume headroom for growth.
Capacity added (current tranche): 600 MT/YearCumulative FY27 capacity added: 6,700 MT/YearExisting installed capacity: 36,000+ MT/YearFY26 capacity utilization: 64%FY26 Total Income: ₹ 35,084.56 Lakhs
📅 Short termPositive operational update demonstrating continuous phased capex rollout, though immediate financial contribution from 600 MT/Year is incremental.
📈 Long termCumulative additions of 6,700 MT/Year provide necessary headroom to achieve management's long-term revenue growth targets as utilization ramps up.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Relatively low capacity utilization (64% in FY26) means revenue realization depends on successful demand generation
- Raw material polymer price volatility can impact margins
Key Highlights
Adds 600 MT/Year manufacturing capacity, expanding base capacity from 36,000+ MT/Year
Cumulative FY27 capacity expansion reaches 6,700 MT/Year across three tranches
Capacity utilization stood at 64% for the financial year ended March 31, 2026
Operates 4 manufacturing facilities in Maharashtra with 57 blow molding and 22 injection molding machines
👀 What to Watch
Track capacity ramp-up and volume growth in upcoming quarterly financial results to evaluate if capacity utilization improves from the FY26 level of 64%.
Mitsu Chem Plast Q1 PAT Surges 566% YoY to ₹8.74 Cr; Plans 3,550 MTPA Capacity Expansion
Mitsu Chem Plast released its Q1 FY27 earnings call transcript, highlighting strong operational performance with total income rising 11.62% YoY to ₹95.33 Cr. EBITDA grew 209.50% YoY to ₹15.49 Cr, with EBITDA margins expanding by 1,041 bps YoY to 16.29% driven by better product mix and efficiency. Net profit surged 566.23% YoY to ₹8.74 Cr (EPS ₹6.44). The company announced a proposed capacity addition of 3,550 MTPA to its existing 32,450 MTPA base, supporting its long-term ambition of achieving ₹1,000 Cr revenue by FY28.
Confidence: HIGH
What changedManagement conducted and disclosed the Q1 FY27 earnings call transcript, detailing drivers behind the margin surge and detailing a 3,550 MTPA brownfield expansion.
Why it mattersDemonstrates strong operational leverage and product rationalization benefits, moving the company closer to its medium-term ₹1,000 Cr top-line goal.
Q1 FY27 Revenue: INR 9,532.78 lakhsQ1 FY27 Net Profit: INR 873.83 lakhsCapacity Addition: 3,550 MTPAExisting Capacity: 32,450 MTPAFY26 Capacity Utilization: 64%FY28 Revenue Target: INR 1,000 crores
📅 Short termEarnings quality and substantial margin expansion are likely to support near-term sentiment following detailed operational disclosures.
📈 Long termCapacity additions and expanding the value-added healthcare furniture (Furnastra) segment are critical to sustaining elevated margins and reaching the FY28 scale target.
⚠ Risk flags
- Raw material (polymer) price volatility tied to geopolitical and crude fluctuations
- Execution and ramp-up risks associated with the capacity expansion
Key Highlights
Q1 FY27 total income grew 11.62% YoY to INR 9,532.78 lakhs (INR 8,540.39 lakhs in Q1 FY26)
EBITDA increased 209.50% YoY to INR 1,549.48 lakhs with margin expanding 1041 bps to 16.29%
Net profit surged 566.23% YoY to INR 873.83 lakhs vs INR 131.16 lakhs in Q1 FY26
Announced planned capacity addition of 3,550 MTPA to existing 32,450 MTPA capacity (+10.9% expansion)
Reiterated long-term objective of reaching INR 1,000 Cr annual revenue by FY28
👀 What to Watch
Track the commissioning timeline and capex spend for the 3,550 MTPA capacity addition, along with sustainability of the 16%+ EBITDA margin in subsequent quarters.
Mitsu Chem Plast to raise up to Rs 15.10 Cr via preferential convertible warrants at Rs 151/share
Mitsu Chem Plast has issued an EGM notice for September 9, 2026, seeking shareholder approval to issue up to 10,00,000 convertible warrants at Rs 151 each, raising up to Rs 15.10 Cr. Promoters Manish Mavji Dedhia and Sanjay Mavji Dedhia will subscribe to 8,00,000 warrants (80% of the issue), while Rikhav Securities Limited will subscribe to 2,00,000 warrants. An upfront payment of 25% (Rs 3.78 Cr) is payable upon subscription, with the remaining 75% due upon conversion within 18 months. The EGM will also vote on regularizing Ms. Drishti Shailesh Thakker as an Independent Director for a 5-year term.
Confidence: HIGH
What changedThe company issued an EGM notice proposing a Rs 15.10 Cr preferential warrant issue to promoters and a non-promoter, along with regularizing an Independent Director appointment.
Why it mattersPromoters are injecting fresh growth capital (Rs 12.08 Cr of the total Rs 15.10 Cr), reinforcing insider commitment and providing equity funding for ongoing capacity expansions at Khalapur.
Total fundraise value: Rs 15.10 CrIssue price per warrant: Rs 151Fundraise vs Market cap: ~6.7%Promoter share of issue: 80%EGM Date: September 9, 2026
📅 Short termApproval at the September 9, 2026 EGM is expected to proceed smoothly, bringing in 25% upfront equity capital (~Rs 3.78 Cr) shortly after allotment.
📈 Long termThe equity infusion strengthens the balance sheet and funds ongoing capacity expansion plans without stretching the existing 0.57 D/E leverage.
⚠ Risk flags
- Equity dilution over the 18-month conversion window
- Dependency on timely warrant conversion to receive the remaining 75% funds
Key Highlights
Preferential issue of up to 10,00,000 convertible warrants at Rs 151 per warrant, aggregating Rs 15.10 Cr
Promoters subscribing to 80% (8,00,000 warrants) and Rikhav Securities subscribing to 20% (2,00,000 warrants)
25% upfront payable at allotment, balance 75% within an 18-month conversion window
EGM scheduled for September 9, 2026, with relevant date set as August 10, 2026
👀 What to Watch
Track the EGM voting results on September 9, 2026, and monitor the subsequent warrant allotment and receipt of initial warrant subscription funds.
Mitsu Chem Plast to raise up to ₹15.1 Cr via 10 lakh warrants at ₹151/share; EGM on Sep 9, 2026
Mitsu Chem Plast has issued a notice for an Extraordinary General Meeting (EGM) on September 09, 2026, seeking shareholder approval to issue up to 10,00,000 convertible warrants at ₹151 per warrant, raising up to ₹15.10 crore. Of the total warrants, 80% (8,00,000 warrants worth ₹12.08 crore) will be allotted to promoters Manish Dedhia and Sanjay Dedhia, while 20% (2,00,000 warrants worth ₹3.02 crore) is allocated to Rikhav Securities Limited. An upfront payment of 25% is payable at subscription, with the remaining 75% due upon conversion within 18 months. Additionally, shareholders will vote on regularizing Ms. Drishti Shailesh Thakker as an Independent Director for a 5-year term.
Confidence: HIGH
What changedThe company has called an EGM to approve a preferential issue of 10 lakh convertible warrants for ₹15.10 crore and the appointment of an Independent Director.
Why it mattersThe fundraise injects fresh equity capital (~6.7% of market cap and ~13.4% of net worth) to support ongoing expansions, while strong promoter participation (80%) signals insider commitment.
Total Warrant Issue Size: ₹15.10 CrIssue Price per Warrant: ₹151Issue Size vs Market Cap: ~6.7%Promoter Allocation: 8,00,000 warrants (80%)Conversion Window: 18 monthsEGM Date: September 09, 2026
📅 Short termExpected to be well-received by the market given promoter equity participation, with immediate focus on shareholder approval on September 9.
📈 Long termProvides equity growth capital to help scale high-margin product lines like healthcare furniture (Furnastra) and fund capex without significantly leveraging the balance sheet.
⚠ Risk flags
- Equity dilution of ~6.8% upon full conversion of warrants into equity shares
- Warrant conversion remains optional over 18 months, with 75% of capital dependent on future exercise
Key Highlights
Proposed issue of up to 10,00,000 warrants at ₹151 each (Face value ₹10 + ₹141 premium), raising up to ₹15.10 crore
Promoters Manish Dedhia (4.75 lakh) and Sanjay Dedhia (3.25 lakh) subscribing to 80% of the total issue
Non-promoter entity Rikhav Securities Limited to be allotted the remaining 2,00,000 warrants (20%)
Conversion terms require 25% payable at subscription and balance 75% payable within an 18-month conversion window
EGM scheduled for September 09, 2026, with the relevant date for pricing set as August 10, 2026
👀 What to Watch
Track shareholder voting results at the September 09, 2026 EGM and subsequent receipt of the 25% upfront subscription money, along with announcements on specific fund deployment.
Q1 FY27 Net Profit Jumps 566% YoY to ₹8.74 Cr; Proposes 3,550 MTPA Expansion and Warrants
Mitsu Chem Plast reported strong Q1 FY27 results with total income rising 11.62% YoY to ₹95.33 Cr. EBITDA surged 209.50% YoY to ₹15.49 Cr as EBITDA margin expanded 1,041 bps to 16.29%, while Net Profit rose 566.23% YoY to ₹8.74 Cr (EPS ₹6.44 vs ₹0.97). The company also announced a capacity addition of 3,550 MT/Year (on existing 32,450+ MT/Year base) and a preferential issue of 10 lakh convertible warrants, raising aggregate promoter stake to 68.61% on a fully diluted basis.
Confidence: HIGH
What changedMitsu Chem Plast declared strong Q1 FY27 results, alongside a proposed 3,550 MTPA capacity expansion and a 10 lakh convertible warrant preferential issue.
Why it mattersOperational efficiencies and higher-value product mix expanded EBITDA margins significantly to 16.29%, while promoter warrant participation increases their holding from 67.77% to 68.61%.
Total Income (Q1 FY27): ₹9,532.78 LakhsNet Profit (Q1 FY27): ₹873.83 LakhsEBITDA Margin: 16.29%Capacity Addition Proposed: 3,550 MT/YearCapacity Addition vs Existing Capacity: ~10.9%Convertible Warrants Proposed: 10 Lakhs
📅 Short termThe sharp earnings jump and margin expansion are likely to be viewed positively by the market, alongside promoter commitment through warrant subscription.
📈 Long termCapacity addition of 3,550 MTPA and transition toward higher-margin hospital furniture and specialized packaging components support long-term revenue growth and margin durability.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Raw material polymer price volatility can impact margins
- FY26 capacity utilization stood at 64%, requiring demand scale-up to absorb new capacity
Key Highlights
Net Profit surged 566.23% YoY to ₹8.74 Cr in Q1 FY27 compared to ₹1.31 Cr in Q1 FY26
EBITDA jumped 209.50% YoY to ₹15.49 Cr, with margins expanding 1,041 bps to 16.29%
Total Income grew 11.62% YoY to ₹95.33 Cr (₹9,532.78 Lakhs)
Proposed capacity addition of 3,550 MT/Year over existing 32,450+ MT/Year capacity
Preferential issuance of 10 lakh convertible warrants to promoters (8 lakh) and non-promoter (2 lakh) taking promoter stake to 68.61%
👀 What to Watch
Track shareholder approvals and pricing terms for the 10 lakh convertible warrants, along with the commissioning timeline of the 3,550 MTPA capacity expansion and margin sustainability in subsequent quarters.
Mitsu Chem Plast Q1 FY27 Revenue at ₹95.15 Cr, Net Profit at ₹8.74 Cr; Reaffirms ₹1,000 Cr FY28 Goal
Mitsu Chem Plast released its Q1 FY27 investor presentation, reporting quarterly revenue of ₹95.15 Cr (₹9,514.53 Lakhs), EBITDA of ₹15.49 Cr, and PAT of ₹8.74 Cr. The company's total installed manufacturing capacity stands at 32,450+ MT across 4 facilities in Maharashtra, housing 53 blow molding and 22 injection molding machines. Management reaffirmed its strategic target to achieve ₹1,000 Cr in annual revenue by FY28, underpinned by expansion in industrial packaging and the dedicated 'Furnastra' hospital furniture brand. Board leadership transitions also took effect in July 2026 with Mr. Jagdish Dedhia as Non-Executive Chairman and Mr. Sanjay Dedhia as Executive Vice Chairman & MD.
Confidence: HIGH
What changedCompany released its Q1 FY27 investor presentation updating operational capacity to 32,450+ MT and outlining financial performance.
Why it mattersShows healthy quarterly profitability and continuous capacity additions across Unit IV Tarapur to support its multi-year ₹1,000 Cr revenue roadmap.
Q1 FY27 Revenue: ₹9,514.53 LakhsQ1 FY27 Net Profit: ₹873.83 LakhsInstalled Capacity: 32,450+ MTTarget FY28 Revenue: ₹1,000 Cr
📅 Short termReflects strong operational performance in Q1 FY27, which supports positive sentiment around margin trajectory.
📈 Long termLong-term value creation depends on scaling hospital furniture margins, expanding exports beyond 17 countries, and executing capacity ramp-ups.
⚠ Risk flags
- Polymer raw material price volatility affecting operating margins
- Execution risks in scaling from ₹350 Cr base to ₹1,000 Cr target by FY28
Key Highlights
Q1 FY27 Revenue stood at ₹9,514.53 Lakhs (₹95.15 Cr) with Net Profit of ₹873.83 Lakhs (₹8.74 Cr).
Installed capacity increased to 32,450+ MT per annum across 4 manufacturing units with 53 blow molding and 22 injection molding machines.
Reiterated long-term vision to achieve ₹1,000 Cr in revenue by FY28 via healthcare furniture and export growth.
Client network spans 700+ customers and 500+ SKUs across 17 export countries.
👀 What to Watch
Track whether quarterly PAT run-rate (~₹8.7 Cr) is sustained in upcoming quarters and monitor progress in scaling the higher-margin Furnastra brand.
Mitsu Chem Plast approves Rs 15.10 Cr preferential warrant issue at Rs 151 per warrant
The Board of Mitsu Chem Plast approved a preferential issue of 10,00,000 convertible warrants at Rs 151 per warrant, aggregating up to Rs 15.10 Cr (representing ~6.8% of its Rs 223 Cr market cap). Promoters Manish and Sanjay Dedhia are subscribing to 80% of the issue (8,00,000 warrants / Rs 12.08 Cr), while non-promoter Rikhav Securities is subscribing to 2,00,000 warrants (Rs 3.02 Cr). 25% (Rs 37.75/warrant) is payable upfront, with the remaining 75% payable within 18 months upon conversion. The company also appointed Ms. Drishti Shailesh Thakker as Independent Director and re-appointed InCorp Advisory Services as Internal Auditor for FY 2026-27.
Confidence: HIGH
What changedBoard approved raising up to Rs 15.10 Cr via preferential warrant allotment primarily to promoters, alongside appointing an independent director and reappointing internal auditors.
Why it mattersPromoter-backed capital infusion provides growth capital and demonstrates promoter confidence, though it entails equity dilution upon conversion over the next 18 months.
Warrant issue size: Rs 15.10 CrIssue size vs Market cap: ~6.8%Warrant issue price: Rs 151Warrants offered: 10,00,000Promoter share of issue: Rs 12.08 Cr (80%)EGM date: September 9, 2026
📅 Short termMarket may view promoter participation positively; monitor shareholder voting approval at the September 9, 2026 EGM.
📈 Long termProvides incremental equity funds to support ongoing business plans, with eventual full conversion expanding the share capital base over an 18-month horizon.
⚠ Risk flags
- Equity dilution of ~7% upon full conversion of 10 lakh warrants into equity shares
- Execution risk on capital deployment and timely receipt of the remaining 75% funds upon conversion
Key Highlights
Preferential issuance of 10,00,000 convertible warrants at Rs 151 each, raising up to Rs 15.10 Cr
Promoters infusing Rs 12.08 Cr (8,00,000 warrants), representing 80% of total proposed fundraise
Upfront cash inflow of Rs 3.775 Cr (25% subscription price of Rs 37.75/warrant) upon allotment
Conversion window valid for up to 18 months on payment of remaining Rs 113.25 per warrant
Extra-Ordinary General Meeting (EGM) scheduled for September 9, 2026 to seek shareholder approval
👀 What to Watch
Track voting outcome at the September 9, 2026 EGM and subsequent warrant allotment and upfront capital receipt.
Mitsu Chem Plast to raise up to Rs 15.10 Cr via preferential warrant issue at Rs 151/share
Mitsu Chem Plast has approved the issuance of up to 10,00,000 convertible warrants at a price of Rs 151 each on a preferential basis, aggregating up to Rs 15.10 crore. Promoters Manish Mavji Dedhia and Sanjay Mavji Dedhia will subscribe to 8,00,000 warrants (Rs 12.08 crore or 80% of the issue), while Rikhav Securities will subscribe to 2,00,000 warrants. An upfront payment of 25% (Rs 37.75 per warrant) is payable at allotment, with the remaining 75% due within 18 months upon conversion. The company has scheduled an Extra-Ordinary General Meeting on September 9, 2026, to seek shareholder approval.
Confidence: HIGH
What changedThe Board approved a preferential issue of 10,00,000 convertible warrants to promoters and an investor to raise up to Rs 15.10 crore.
Why it mattersProvides fresh equity funding representing ~6.8% of market cap with strong promoter participation, bolstering the balance sheet for ongoing expansion plans.
Total fundraise: Rs 15.10 crIssue price per warrant: Rs 151Total warrants offered: 10,00,000Fundraise vs Market cap: ~6.8%Upfront payment (25%): Rs 37.75 per warrantEGM Date: September 9, 2026
📅 Short termMarket may view the high promoter participation (80%) positively, balancing the slight discount of the Rs 151 issue price against recent market prices.
📈 Long termStrengthens capital reserves to support the company's multi-year growth strategy, though it will result in minor equity dilution upon final conversion over the 18-month tenure.
⚠ Risk flags
- Equity dilution of ~7% upon full conversion of warrants
- Staggered fund inflow as 75% of funds are payable only at warrant exercise over 18 months
Key Highlights
Preferential issuance of up to 10,00,000 convertible warrants at Rs 151 each, raising up to Rs 15.10 crore
Promoter backing: 8,00,000 warrants (80% of issue) allocated to promoters Manish and Sanjay Dedhia
Non-promoter allocation: 2,00,000 warrants allocated to Rikhav Securities Limited
Payment terms: 25% (Rs 37.75/warrant) upfront with conversion exercisable within 18 months
Extra-Ordinary General Meeting (EGM) convened on September 9, 2026, for shareholder approval
👀 What to Watch
Track the shareholder voting outcome at the EGM on September 9, 2026, and watch for subsequent warrant allotment and deployment of proceeds into capacity expansion.
Mitsu Chem Plast to raise up to ₹15.10 Cr via 10 lakh convertible warrants at ₹151 each
The Board of Directors of Mitsu Chem Plast Ltd has approved a preferential issue of up to 10,00,000 convertible warrants at ₹151 per warrant, aggregating to ₹15.10 Cr. Promoters Manish Mavji Dedhia and Sanjay Mavji Dedhia are subscribing to 8,00,000 warrants (₹12.08 Cr / 80% of total), while non-promoter Rikhav Securities Limited is subscribing to 2,00,000 warrants (₹3.02 Cr). An upfront amount of 25% (₹37.75 per warrant) is payable on allotment, with the balance 75% (₹113.25 per warrant) payable upon conversion within 18 months. An Extra-Ordinary General Meeting (EGM) is scheduled for September 9, 2026 to seek shareholder approval.
Confidence: HIGH
What changedThe Board approved a ₹15.10 Cr fundraise via convertible warrants to promoters and an investor, and appointed Drishti Shailesh Thakker as Independent Director.
Why it mattersThe fundraise injects capital equivalent to ~6.8% of current market cap and ~13.4% of net worth, with promoters providing 80% of the funds, bolstering the balance sheet for growth initiatives.
Total Fundraise Amount: Rs. 15,10,00,000Warrants Proposed: 10,00,000Issue Price per Warrant: Rs. 151Fundraise vs Market Cap: ~6.8%Promoter Contribution: Rs. 12.08 CrEGM Date: September 9, 2026
📅 Short termPromoter backing at ₹151 per share is likely to provide valuation support, with near-term attention on EGM approval on September 9, 2026.
📈 Long termStrengthens the equity base (net worth of ₹113 Cr) and provides funding flexibility to support the company's multi-year expansion targets.
⚠ Risk flags
- Equity dilution of up to 10 lakh shares upon full warrant conversion
- Balance 75% capital inflow depends on warrant holders exercising within the 18-month window
Key Highlights
Preferential issuance of up to 10,00,000 convertible warrants at ₹151 per warrant, raising ₹15.10 Cr
Promoters subscribing to 80% of the issue (8,00,000 warrants worth ₹12.08 Cr)
Non-promoter Rikhav Securities Limited allotted 2,00,000 warrants worth ₹3.02 Cr
25% upfront subscription (₹37.75/warrant) with 18 months tenure to exercise balance 75% (₹113.25/warrant)
EGM convened on September 9, 2026 for shareholder approval
👀 What to Watch
Track the outcome of the shareholder voting at the EGM on September 9, 2026, and monitor the timeline for warrant allotment and cash realization.
Mitsu Chem Plast Approves Rs 15.10 Cr Preferential Warrant Issue at Rs 151/Warrant
Mitsu Chem Plast's Board has approved the issuance of up to 10,00,000 convertible warrants on a preferential basis at Rs 151 each, raising up to Rs 15.10 crore. Promoters Manish Mavji Dedhia and Sanjay Mavji Dedhia will subscribe to 8,00,000 warrants (Rs 12.08 crore or 80% of the issue), while Rikhav Securities Limited is allocated 2,00,000 warrants (Rs 3.02 crore). An upfront 25% (Rs 37.75/warrant) is payable on allotment, with the remaining 75% due upon conversion within 18 months. The fundraise equals ~6.8% of the company's Rs 223 crore market capitalization.
Confidence: HIGH
What changedBoard approved raising Rs 15.10 crore through a preferential issue of 10 lakh convertible warrants at Rs 151 per share.
Why it mattersInfuses fresh equity capital (~13.4% of net worth) with 80% promoter participation, supporting ongoing capacity expansion and business transformation initiatives.
Total Issue Size: Rs 15.10 CrWarrant Issue Price: Rs 151Fundraise vs Market Cap: ~6.77%Promoter Contribution: Rs 12.08 Cr (80%)Upfront Payment per Warrant: Rs 37.75EGM Date: September 9, 2026
📅 Short termMarket may view promoter capital backing positively, though attention will turn to EGM voting on September 9, 2026.
📈 Long termStrengthens equity base to support long-term expansion goals and value-added product development across industrial packaging and healthcare furniture.
⚠ Risk flags
- Equity dilution of up to 10 lakh shares upon warrant conversion over the next 18 months.
- Pending approval from shareholders at the EGM and stock exchanges.
Key Highlights
Approved issuance of 10,00,000 convertible warrants at Rs 151 per warrant, aggregating Rs 15.10 crore.
Promoters to infuse Rs 12.08 crore (8,00,000 warrants), demonstrating insider commitment.
Non-promoter Rikhav Securities Limited allocated 2,00,000 warrants worth Rs 3.02 crore.
25% upfront payment (Rs 37.75/warrant) required, with conversion window extending up to 18 months.
Extra-Ordinary General Meeting (EGM) scheduled for September 9, 2026, to seek shareholder approval.
👀 What to Watch
Track voting outcomes at the upcoming EGM on September 9, 2026, along with subsequent warrant allotment timelines and conversion tranches.
3,550 MT/Year Capacity Addition: Mitsu Chem Plast Expands Manufacturing by ~11%
Mitsu Chem Plast has announced a capacity addition of 3,550 MT/Year, representing an approximate 10.9% increase over its existing base of 32,450 MT/Year. This expansion is designed to support the company's long-term goal of tripling revenue by 2028 through product diversification into higher-margin segments like healthcare furniture and industrial pails. While current capacity utilization stands at 64% as of FY26, the new infrastructure provides the headroom required for its 'Four Pillars of Transformation' strategy. The company reported a TTM revenue of ₹350 Cr with a net profit of ₹16 Cr.
Confidence: HIGH
What changedThe company is increasing its total manufacturing capacity by approximately 11% to support its 2028 growth roadmap.
Why it mattersThis expansion provides the necessary manufacturing headroom to scale new, higher-margin product lines like 'Furnastra' healthcare furniture and specialized industrial packaging, reducing reliance on commodity-grade products.
Capacity Addition: 3,550 MT/YearExisting Capacity: 32,450 MT/YearCapacity Increase (%): 10.9%FY26 Capacity Utilization: 64%TTM Revenue: ₹350 CrCustomer Count: 700+
📅 Short termThe announcement is likely to be viewed positively as a signal of management's confidence in demand, though immediate financial impact will depend on the speed of machinery installation.
📈 Long termStructurally significant as it aligns with the company's target to reach ₹1,000 Cr revenue by 2028 and expand its export footprint beyond the current 17 countries.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Current idle capacity (36%) suggests a need for strong order book execution to justify further expansion
- Sensitivity to polymer price volatility impacting margins
Key Highlights
Proposed capacity addition of 3,550 MT/Year to the existing 32,450+ MT/Year base.
Existing capacity utilization reported at 64% for the fiscal year ended March 31, 2026.
Infrastructure includes 4 manufacturing facilities in Maharashtra with 53 blow molding and 22 injection molding machines.
Company serves a diversified base of 700+ customers, including 30+ Fortune 500 companies in India.
FY26 financial performance showed Total Income of ₹350.84 Cr and Net Profit of ₹15.61 Cr.
👀 What to Watch
Watch for improvements in capacity utilization from the current 64% level and the execution timeline for the new machinery to translate into revenue growth.
10.9% Capacity Addition: Mitsu Chem Plast to add 3,550 MT/Year in August 2026
Mitsu Chem Plast is expanding its manufacturing capacity by approximately 3,550 MT/Year, a 10.9% increase over its current base of 32,450+ MT/Year. The expansion requires a modest investment of Rs 1.94 Cr (INR 194 lakhs), which will be funded through a mix of bank finance and internal accruals. The project is slated for immediate completion within August 2026. Despite a current utilization rate of 64% as of March 2026, the company is adding capacity to support product diversification and its long-term revenue target of INR 1,000 Cr by 2028.
Confidence: HIGH
What changedThe company is increasing its total operational capacity by ~11% through a Rs 1.94 Cr investment in new machinery.
Why it mattersThis expansion is a tactical step toward the company's goal of tripling revenue by 2028. It specifically targets product diversification, which is critical for improving OPM from the current 10% level.
Existing Capacity: 32,450+ MT/YearProposed Addition: 3,550 MT/YearCapacity Increase (%): 10.9%Investment Value: Rs 1.94 CrInvestment vs Net Worth: 1.71%FY26 Utilization: 64%
📅 Short termThe immediate completion timeline (August 2026) is positive, though the small scale of capex relative to market cap suggests limited immediate stock price impact.
📈 Long termThe expansion supports the company's structural shift toward specialized plastic products and healthcare furniture, which are key to achieving its 2028 growth targets.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Existing capacity utilization is relatively low at 64%, indicating a need for strong demand generation to justify new capacity.
Key Highlights
Proposed capacity addition of approximately 3,550 MT/Year to the existing 32,450+ MT/Year.
Total investment for machinery is approximately Rs 1.94 Cr (INR 194 lakhs).
Expansion is scheduled to be completed within the current month, August 2026.
Existing capacity utilization stood at 64% for the fiscal year ended March 31, 2026.
Funding to be sourced through a combination of Bank Finance and Internal Accruals.
👀 What to Watch
Investors should monitor if this capacity addition leads to a pick-up in revenue growth in the H2 FY27 results, particularly in the higher-margin healthcare furniture and 'PAILS' segments.
Mitsu Chem Plast Proposes 150% Increase in Borrowing Limit to ₹500 Cr at 38th AGM
Mitsu Chem Plast has scheduled its 38th Annual General Meeting (AGM) for July 31, 2026. The company is seeking shareholder approval for a significant increase in borrowing limits from ₹200 crores to ₹500 crores, alongside the creation of security on assets for the same amount. Other key agenda items include the declaration of a final dividend for FY26 and a major management restructuring, including the transition of the Chairman to a non-executive role and remuneration increases for executive directors.
Confidence: HIGH
What changedThe company is seeking to more than double its debt capacity and is undergoing a significant reshuffle of its board and executive leadership roles.
Why it mattersThe substantial increase in borrowing headroom (₹300 crore additional) suggests the company is preparing for a major expansion phase or strategic investment that exceeds its current financial framework.
Current Borrowing Limit: ₹200 croresProposed Borrowing Limit: ₹500 croresAGM Date: July 31, 2026MD & CFO FY26 Remuneration: ₹121.50 LakhsProposed Asset Security Limit: ₹500 crores
📅 Short termThe market may view the increased borrowing limit as a precursor to expansion, though the immediate focus will be on the dividend declaration details.
📈 Long termThe management transition and significantly higher borrowing capacity indicate a structural shift towards a larger scale of operations, provided the capital is deployed efficiently.
⚠ Risk flags
- Potential for significantly higher leverage if the ₹500 crore limit is fully utilized
- Related-party remuneration increases for executive directors
Key Highlights
Proposed increase in borrowing limits under Section 180(1)(c) from ₹200 crores to ₹500 crores.
38th AGM scheduled for July 31, 2026, to transact 12 specific resolutions.
Management restructuring: Mr. Jagdish Dedhia to move from Chairman & WTD to Non-Executive Chairman.
Remuneration of Mr. Manish Dedhia (MD & CFO) was ₹121.50 Lakhs for FY 2025-26.
Appointment of Mr. Ajit Eledath Venugopalan as Independent Director for a 5-year term starting May 28, 2026.
👀 What to Watch
Investors should monitor the voting results of the AGM, particularly the approval of the ₹500 crore borrowing limit, which signals potential upcoming capital expenditure or acquisitions.
Mitsu Chem Plast Announces Major Board Restructuring and 5-Year Management Appointments
Mitsu Chem Plast has restructured its top leadership effective July 07, 2026, for five-year terms. Jagdish Dedhia transitions from Chairman & Whole Time Director to Non-Executive Chairman, while Sanjay Dedhia is elevated to Executive Vice Chairman & Managing Director. Manish Dedhia has been re-appointed as MD & CFO, and Pankaj Gharat (General Manager – Operations since 2011) joins the Board as an Additional Director. These appointments and revised remuneration packages are subject to shareholder approval at the 38th AGM on July 31, 2026.
Confidence: HIGH
What changedThe company has shifted its senior-most promoter to a non-executive role and elevated a long-term operations head to the Board of Directors.
Why it mattersThis restructuring ensures leadership continuity for the next five years while formalizing the role of operational management at the board level, which is critical for a manufacturing-focused business.
Jagdish Dedhia Experience: 35+ yearsSanjay Dedhia Experience: 31 yearsPankaj Gharat Experience: 33 yearsAppointment Term: 5 yearsAGM Date: July 31, 2026
📅 Short termThe market is likely to view this as a routine succession and governance update; no immediate impact on stock price is expected.
📈 Long termThe 5-year commitment from the core management team provides stability for the company's growth plans in the industrial packaging and value-added plastics sector.
⚠ Risk flags
- Related-party concentration (three Dedhia family members in key leadership roles)
Key Highlights
Jagdish Dedhia transitions to Non-Executive Chairman after 35+ years of experience in the industry.
Sanjay Dedhia elevated to Executive Vice Chairman & MD for a 5-year term starting July 07, 2026.
Manish Dedhia re-appointed as MD & CFO for a 5-year term to oversee financial strategies.
Pankaj Gharat, with 33 years of experience and 15 years at the company, appointed as Additional Director (Executive).
38th Annual General Meeting scheduled for July 31, 2026, to ratify these changes.
👀 What to Watch
Investors should monitor the 38th AGM results on July 31, 2026, and review the upcoming AGM notice for specific details on the 'revision in remuneration' for the Managing Directors.
